Jump to content

Where’s The Promised Transparency In Drug...


Recommended Posts

Issues & Insights

Hospitals are shoring up their balance sheets on the backs of cancer patients, according to a new study published in JAMA Internal Medicine.

Researchers looked at 25 of the top cancer medications distributed at 61 cancer treatment centers across the country over the course of six months. They found that the clinics charged private insurers anywhere from 118% to 634% above what it cost them to acquire the drug.

It shouldn’t take a team of medical researchers to find out how much providers are charging for their services. If price transparency were the norm in the healthcare marketplace, then providers wouldn’t be able to get away with such outlandish mark-ups.:snip:

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • 1716031015
  • Create New...